18F-FDG PET/CT对肝细胞癌患者肝移植前血管侵犯的预测价值
本回顾性研究纳入2010年1月至2012年7月间65例肝移植前接受18F-FDG PET/CT的肝细胞癌患者,测量肿瘤SUVmax、肿瘤与正常肝脏SUVmax比值(TSUVmax/LSUVmax)及肿瘤SUVmax与正常肝脏SUVmean比值(TSUVmax/LSUVmean)。65例中15例(23.08%)病理证实血管侵犯;多因素分析显示TSUVmax/LSUVmean比值是血管侵犯的显著预测因子(P=0.04),TSUVmax/LSUVmax比值为独立预测因子但呈边缘统计学意义(P=0.06)。
要点
- 65例肝移植前肝细胞癌患者中15例(23.08%)病理证实存在血管侵犯。
- 血管侵犯组血清AFP(P<0.001)、肿瘤大小(P=0.001)、肿瘤数目(P=0.017)及SUVmax、TSUVmax/LSUVmax、TSUVmax/LSUVmean均高于无血管侵犯组。
- 多因素分析示TSUVmax/LSUVmean比值是血管侵犯的显著预测因子(P=0.04),TSUVmax/LSUVmax比值P=0.06为边缘显著。
核心结论
- TSUVmax/LSUVmean比值是肝移植前肝细胞癌患者血管侵犯的独立且显著的预测因子。
- TSUVmax/LSUVmax比值是血管侵犯的独立预测因子,但该发现在本研究中呈边缘统计学意义(P=0.06)。
- 作者认为FDG PET/CT可为判断预后和选择肝移植最佳候选者提供重要信息。
研究设计与样本
- 回顾性研究,纳入2010年1月至2012年7月间65例肝移植前接受18F-FDG PET/CT的肝细胞癌患者。
- 对肿瘤和正常肝组织勾画感兴趣区(VOI),测量各VOI的标准化摄取值(SUV)。
- 测量指标包括肿瘤最大SUV(SUVmax)、肿瘤SUVmax与正常肝脏SUVmax比值(TSUVmax/LSUVmax)、肿瘤SUVmax与正常肝脏SUVmean比值(TSUVmax/LSUVmean),并分析代谢参数及传统预后因素的预测价值。
主要发现
- 65例中15例(23.08%)经病理证实存在血管侵犯。
- 与无血管侵犯组相比,血管侵犯组血清AFP更高(P<0.001)、肿瘤更大(P=0.001)、肿瘤数目更多(P=0.017)。
- 血管侵犯组SUVmax、TSUVmax/LSUVmax比值、TSUVmax/LSUVmean比值均高于无血管侵犯组(P=0.008、P=0.002、P=0.006)。
- 单因素分析显示SUVmax、TSUVmax/LSUVmax比值、TSUVmax/LSUVmean比值均与血管侵犯显著相关(P=0.019、P=0.018、P=0.015)。
- 多因素分析显示TSUVmax/LSUVmean比值是血管侵犯的显著预测因子(P=0.04),TSUVmax/LSUVmax比值为独立预测因子但呈边缘统计学意义(P=0.06)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Positron emission tomography-computed tomography using F-fluorodeoxyglucose (F-FDG PET/CT) has been widely used in oncology. Vascular invasion of hepatocellular carcinoma (HCC) is associated with a high risk of tumor recurrence and low survival rates after liver transplantation (LT). This retrospective study determined the predictive value of F-FDG PET/CT for vascular invasion in patients with HCC before LT. METHODS: Sixty-five patients with HCC who underwent F-FDG PET/CT before LT were retrospectively included between January 2010 and July 2012. Volumes of interest (VOIs) were drawn for the tumors and normal liver tissues, and the standardized uptake value (SUV) in each VOI was measured. The maximal SUV (SUVmax) of the tumor, the ratio of tumor SUVmax to normal liver SUVmax (TSUVmax/LSUVmax), and the ratio of tumor SUVmax to normal liver SUVmean (TSUVmax/LSUVmean) were measured. The predictive value of metabolic parameters and conventional prognostic factors were analyzed. RESULTS: Vascular invasion was pathologically confirmed in 15 (23.08%) of 65 patients. Compared with patients without vascular invasion, patients with vascular invasion exhibited significantly higher serum alpha-fetoprotein (AFP) (P < 0.001), larger tumor size (P = 0.001), higher tumor number (P = 0.017), and higher SUVmax, TSUVmax/LSUVmax ratio, and higher TSUVmax/LSUVmean ratio (P = 0.008, P = 0.002, and P = 0.006, respectively). Univariate analysis revealed that SUVmax, TSUVmax/LSUVmax ratio, and TSUVmax/LSUVmean ratio of FDG PET/CT were significantly associated with vascular invasion in patients with HCC before LT (P = 0.019, P = 0.018, and P = 0.015, respectively). Multivariate analysis revealed that the TSUVmax/LSUVmean ratio of F-FDG PET/CT was a significant predictor of vascular invasion (P = 0.04) and that the TSUVmax/LSUVmax ratio of F-FDG PET/CT was an independent predictor of vascular invasion, although this finding demonstrated borderline statistical significance (P = 0.06) in patients with HCC before LT. CONCLUSIONS: According to the study results, the TSUVmax/LSUVmean ratio is an independent and significant predictor of vascular invasion, and the TSUVmax/LSUVmax ratio of F-FDG PET/CT is an independent predictor of vascular invasion, which is the main negative outcome after LT. Therefore, FDG PET/CT can provide vital information for determining prognosis and selecting an optimal candidate of LT for HCC.
引用
- Lin CY, Liao CW, Chu LY, et al. Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation. Clin Nucl Med. 2017. PMID: 28114226. doi:10.1097/RLU.0000000000001545
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。